{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:50:53Z","timestamp":1774615853215,"version":"3.50.1"},"reference-count":25,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary hyperparathyroidism (PHPT) is the most common etiology of hypercalcemia in an ambulatory setting and often arises from adenomatous growth of one (occasionally more than one) parathyroid gland. Patients with severe and symptomatic hypercalcemia, renal insufficiency, nephrolithiasis, osteoporosis, and younger than 50 are candidates for surgical removal of parathyroid adenoma(s). Medical treatment with a calcimimetic agent is offered to improve severe hypercalcemia when surgery is refused or considered unsafe. Here, we report a 68-year-old man with severe hypercalcemia due to PHPT and coronary artery disease who had to undergo percutaneous coronary intervention and stent placement. Surgery for PHPT was delayed for 6 months, and he received cinacalcet to lower serum calcium. He developed hypocalcemia 6 months later. After discontinuation of cinacalcet, his serum calcium remained normal. Ultrasonography of the anterior neck showed again a hypoechoic lesion posterior to the right thyroid lobe (presumed to be a parathyroid adenoma) but with smaller dimensions. This case highlights a rare but clinically significant phenomenon: the possibility of durable remission and anatomical regression of parathyroid adenoma following cinacalcet administration.<\/jats:p>","DOI":"10.1210\/jcemcr\/luag014","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:44:44Z","timestamp":1768481084000},"source":"Crossref","is-referenced-by-count":0,"title":["Unanticipated remission of primary hyperparathyroidism following cinacalcet"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-0589","authenticated-orcid":false,"given":"Sara","family":"Ramadan","sequence":"first","affiliation":[{"name":"Department of Medicine, Boston Medical Center Brighton, Boston University Chobanian & Avedisian School of Medicine , Boston, MA 02135 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1236-7980","authenticated-orcid":false,"given":"Shirin","family":"Haddady","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes and Weight Management, Boston Medical Center, Boston University Chobanian & Avedisian School of Medicine , Boston, MA 02118 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"5","key":"2026032707552112400_luag014-B1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","article-title":"Secondary and tertiary hyperparathyroidism, state of the art surgical management","volume":"89","author":"Pitt","year":"2009","journal-title":"Surg Clin North Am"},{"issue":"3","key":"2026032707552112400_luag014-B2","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026032707552112400_luag014-B3","doi-asserted-by":"crossref","first-page":"bvae096","DOI":"10.1210\/jendso\/bvae096","article-title":"Patient characteristics, management, and outcomes in a novel cohort of primary hyperparathyroidism","volume":"8","author":"Sant","year":"2024","journal-title":"J Endocr Soc"},{"issue":"10116","key":"2026032707552112400_luag014-B4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","article-title":"Hyperparathyroidism","volume":"391","author":"Bilezikian","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"2026032707552112400_luag014-B5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"issue":"2","key":"2026032707552112400_luag014-B6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/jc.2008-1758","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032707552112400_luag014-B7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1210\/jc.2008-1761","article-title":"The surgical management of primary hyperparathyroidism: proceedings of the third international workshop","volume":"94","author":"Udelsman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026032707552112400_luag014-B8","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/jbmr.4670","article-title":"The fifth international workshop on the evaluation and management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026032707552112400_luag014-B9","doi-asserted-by":"crossref","first-page":"bvaf021","DOI":"10.1210\/jendso\/bvaf021","article-title":"Pharmacodynamic modeling of cinacalcet in secondary hyperparathyroidism: efficacy and influencing factors analysis","volume":"9","author":"Wang","year":"2025","journal-title":"J Endocr Soc"},{"key":"2026032707552112400_luag014-B10","article-title":"Cinacalcet","author":"Helbing","journal-title":"StatPearls [Internet]"},{"key":"2026032707552112400_luag014-B11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphys.2016.00563","article-title":"The calcium-sensing receptor and the parathyroid: past, present, future","volume":"7","author":"Conigrave","year":"2016","journal-title":"Front Physiol"},{"issue":"11","key":"2026032707552112400_luag014-B12","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/jbmr.4682","article-title":"Management of primary hyperparathyroidism","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026032707552112400_luag014-B13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1530\/EC-20-0221","article-title":"Cinacalcet and primary hyperparathyroidism: systematic review and meta-regression","volume":"9","author":"Ng","year":"2020","journal-title":"Endocr Connect"},{"issue":"5","key":"2026032707552112400_luag014-B14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1530\/EJE-14-0877","article-title":"Cinacalcet normalizes serum calcium in primary hyperparathyroidism: a double-blind randomized controlled trial","volume":"172","author":"Khan","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026032707552112400_luag014-B15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00223-011-9490-4","article-title":"Cinacalcet suppresses parathyroid cell proliferation","volume":"89","author":"Imanishi","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"2026032707552112400_luag014-B16","first-page":"190","article-title":"Asymptomatic primary hyperparathyroidism: a perspective","volume":"9","author":"Silverberg","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"2026032707552112400_luag014-B17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3389\/fendo.2018.00777","article-title":"Parathyroid apoplexy following cinacalcet treatment in primary hyperparathyroidism","volume":"9","author":"Di Dalmazi","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026032707552112400_luag014-B18","doi-asserted-by":"crossref","first-page":"2324709620936836","DOI":"10.1177\/2324709620936836","article-title":"Cinacalcet-associated resolution of primary hyperparathyroidism in a patient with normal kidney function","volume":"8","author":"Nguyen","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2026032707552112400_luag014-B19","first-page":"EP241","article-title":"9-year remission of severe primary hyperparathyroidism after high-dose cinacalcet","volume":"99","author":"Krcma","year":"2024","journal-title":"Endocr Abstr"},{"key":"2026032707552112400_luag014-B20","first-page":"P191","article-title":"Spontaneous remission of hypercalcaemia in primary hyperparathyroidism due to necrosis of parathyroid adenoma after cinacalcet","volume":"94","author":"Wahid","year":"2023","journal-title":"Endocr Abstr"},{"issue":"4","key":"2026032707552112400_luag014-B21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00774-020-01190-2","article-title":"Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism","volume":"39","author":"Minezaki","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"2026032707552112400_luag014-B22","doi-asserted-by":"crossref","first-page":"766234","DOI":"10.3389\/fendo.2021.766234","article-title":"Spontaneous remission after a hypercalcemic crisis caused by an intracystic hemorrhage of bilateral parathyroid adenomas: a case report and literature review","volume":"12","author":"Liu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2026032707552112400_luag014-B23","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00005792-199811000-00005","article-title":"Remission of primary hyperparathyroidism due to spontaneous infarction of a parathyroid adenoma: case report and review of the literature","volume":"77","author":"Kovacs","year":"1998","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2026032707552112400_luag014-B24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/000313480206800215","article-title":"Spontaneous infarction of a parathyroid adenoma: two case reports and review of the literature","volume":"68","author":"Lucas","year":"2002","journal-title":"Am Surg"},{"issue":"2","key":"2026032707552112400_luag014-B25","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1210\/jcem.86.2.7207","article-title":"Parathyroid carcinoma","volume":"86","author":"Shane","year":"2001","journal-title":"J Clin Endocrinol Metab"}],"container-title":["JCEM Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/4\/luag014\/67595691\/luag014.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcemcr\/article-pdf\/4\/4\/luag014\/67595691\/luag014.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:55:32Z","timestamp":1774612532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcemcr\/article\/doi\/10.1210\/jcemcr\/luag014\/8550288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,19]]}},"URL":"https:\/\/doi.org\/10.1210\/jcemcr\/luag014","relation":{},"ISSN":["2755-1520"],"issn-type":[{"value":"2755-1520","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,19]]},"article-number":"luag014"}}